Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

94.91 -0.19 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 488,780
Open 94.84
Bid (Size) 94.95 (1)
Ask (Size) 100.00 (1)
Prev. Close 95.10
Today's Range 94.14 - 95.91
52wk Range 50.20 - 126.89
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NASDAQ:LNTH is not too expensive for the growth it is showing.
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced. 
Via Chartmill
NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Don't overlook LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill

Performance

YTD
+50.41%
+50.41%
1 Month
-21.96%
-21.96%
3 Month
+19.13%
+19.13%
6 Month
+65.18%
+65.18%
1 Year
+44.11%
+44.11%

More News

Read More
Lantheus Reports Second Quarter 2024 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
Via Chartmill
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Is NASDAQ:LNTH on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
Russell 2000 Marks Fifth Day Of Gains: What's Driving Surge In Small-Cap Stocks?
Via Benzinga
Topics ETFs
Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
From Lantheus Holdings, Inc.
Via GlobeNewswire
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Via Benzinga
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
Via Benzinga
Topics Economy
Exposures Interest Rates
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
New Reimbursement Rules For Diagnostic Radiopharmaceuticals Is 'Undoubtedly' Positive for Lantheus: Analyst
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
From Lantheus Holdings, Inc.
Via GlobeNewswire
Why Lantheus Holdings Stock Is Skyrocketing Today
Via The Motley Fool
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Lantheus Stock Gets A Radioactive Surge On Medicare Proposal
Via Investor's Business Daily
Lantheus Appoints Jamie Spaeth as Chief People Officer
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.
Via Chartmill
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
From Lantheus Holdings, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.